Literature DB >> 23024938

Role of measurement of antioxidant enzymes in evaluation of antioxidant therapy in tobacco abusers with oral leukoplakia.

R K Jain1, Gautam Bir Singh, Arvinder Pal Singh, R K Goel, N C Aryya, Sandeep K Jha.   

Abstract

Antioxidants are widely used in chemoprevention of malignancy. Numerous studies in medical literature have reported the evaluation of this treatment protocol by indirect methodology-epidemiology, invitro studies, pharmacology and animal models etc. However, there is a paucity of literature on the measurement of antioxidant enzymes as a parameter for assessing the outcome of antioxidant therapy. This study explores the efficacy and outcome of antioxidant enzyme assay in relation to antioxidant therapy in tobacco abusers, hitherto unreported in medical literature. A prospective cohort study with control in 50 patients carried out at a tertiary care teaching Institution (Institute of Medical Sciences, Banaras Hindu University, Varanasi, India). Out of these patients, 10 patients acted as control, rest 40 patients-all tobacco users in some form, were divided into three groups on the basis of histopathological grading of dysplasia-no dysplasia, mild or moderate dysplasia. The levels of Lipid peroxidase (LPO), Superoxide dismutase (SOD) and Catalase (CAT) in mucosa and serum were assayed in each group, and re-evaluated at the end of 3 months after intervention with antioxidant treatment. To detect any alteration in degree of dysplasia a repeat biopsy was also done at the end of 3 months. The results were statistically analysed using paired t test. A statistically significant decrease in level of LPO and SOD, and an increase in CAT levels were recorded both in mucosa and serum. However, no change in dysplasia and no new case of dysplasia were observed. Further, antioxidant treatment was continued for a year and the final out come of the lesion was assessed by "Carter's criteria". A final success rate of 74.19% was recorded in terms of partial or complete regression of the lesion. This study confirms the therapeutic efficacy of antioxidants in oral leukoplakia, and cites the importance of LPO, SOD and CAT in evaluating the efficacy of antioxidant treatment. However, the study failed to elucidate any relationship between enzyme measurement and the final outcome of the lesion.

Entities:  

Keywords:  Antioxidant; Antioxidant enzymes; Catalase; Leukoplakia; Lipid peroxidase; Superoxide dismutase

Year:  2011        PMID: 23024938      PMCID: PMC3227828          DOI: 10.1007/s12070-011-0266-y

Source DB:  PubMed          Journal:  Indian J Otolaryngol Head Neck Surg        ISSN: 2231-3796


  28 in total

Review 1.  Premalignant lesions: role of antioxidant vitamins and beta-carotene in risk reduction and prevention of malignant transformation.

Authors:  V N Singh; S K Gaby
Journal:  Am J Clin Nutr       Date:  1991-01       Impact factor: 7.045

Review 2.  Mechanisms involved in the generation of free radicals.

Authors:  B Halliwell
Journal:  Pathol Biol (Paris)       Date:  1996-01

Review 3.  Free radicals, antioxidant enzymes, and carcinogenesis.

Authors:  Y Sun
Journal:  Free Radic Biol Med       Date:  1990       Impact factor: 7.376

Review 4.  Molecular genetics of superoxide dismutases.

Authors:  D Touati
Journal:  Free Radic Biol Med       Date:  1988       Impact factor: 7.376

5.  Heterogeneity of erythrocyte catalase II. Isolation and characterization of normal and variant erythrocyte catalase and their subunits.

Authors:  H Aebi; S R Wyss; B Scherz; F Skvaril
Journal:  Eur J Biochem       Date:  1974-10-01

6.  Beta-carotene produces sustained remissions in patients with oral leukoplakia: results of a multicenter prospective trial.

Authors:  H S Garewal; R V Katz; F Meyskens; J Pitcock; D Morse; S Friedman; Y Peng; D G Pendrys; S Mayne; D Alberts; T Kiersch; E Graver
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1999-12

7.  Regression of oral leukoplakia with alpha-tocopherol: a community clinical oncology program chemoprevention study.

Authors:  S E Benner; R J Winn; S M Lippman; J Poland; K S Hansen; M A Luna; W K Hong
Journal:  J Natl Cancer Inst       Date:  1993-01-06       Impact factor: 13.506

8.  Efficacy of oral lycopene in the treatment of oral leukoplakia.

Authors:  Mohitpal Singh; R Krishanappa; Anjana Bagewadi; Vaishali Keluskar
Journal:  Oral Oncol       Date:  2004-07       Impact factor: 5.337

9.  Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with beta-carotene and with beta-carotene plus vitamin A.

Authors:  H F Stich; M P Rosin; A P Hornby; B Mathew; R Sankaranarayanan; M K Nair
Journal:  Int J Cancer       Date:  1988-08-15       Impact factor: 7.396

Review 10.  Antioxidants in oral cancer prevention.

Authors:  H Garewal
Journal:  Am J Clin Nutr       Date:  1995-12       Impact factor: 7.045

View more
  1 in total

Review 1.  Redox Changes Induced by General Anesthesia in Critically Ill Patients with Multiple Traumas.

Authors:  Marius Papurica; Alexandru Florin Rogobete; Dorel Sandesc; Raluca Dumache; Radu Nartita; Mirela Sarandan; Alina Carmen Cradigati; Loredana Luca; Corina Vernic; Ovidiu Horea Bedreag
Journal:  Mol Biol Int       Date:  2015-11-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.